Yang Quancheng, Lv Yi, Gao Shenrong, Zhang Yu, Zhai Xuejia
Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Hubei Province Clinical Research Center for Precision Medicine for Critical Illness, Wuhan, China.
Front Psychol. 2025 May 21;16:1529339. doi: 10.3389/fpsyg.2025.1529339. eCollection 2025.
Although perinatal depression (PND) has garnered increasing attention, few specific pharmacological treatments exist, particularly for breastfeeding mothers concerned about antidepressant safety. The misconception that "natural is harmless" merits caution; herbal remedies and dietary supplements should be regarded as supplementary interventions pending robust safety evidence. This review summarizes recent advances in PND pathogenesis (neurotransmitter dysregulation, inflammation, hormonal imbalance, and microbiota alterations) and emerging drug development strategies, alongside clinical evidence for herbal and dietary supplements. Randomized controlled trial (RCT) findings reveal that while interventions like saffron and vitamin D show promise, significant limitations persist, including inconsistent efficacy, limited long-term safety data, and potential interactions with perinatal physiology. Caution is warranted until comprehensive studies validate the safety and reliability of natural interventions. This review underscores the need for rigorous trials to identify safe, effective PND treatments, particularly for vulnerable populations.
尽管围产期抑郁症(PND)已受到越来越多的关注,但针对它的特异性药物治疗却很少,尤其是对于担心抗抑郁药安全性的哺乳期母亲而言。“天然即无害”这种误解值得警惕;在有充分的安全证据之前,草药疗法和膳食补充剂应被视为辅助干预措施。本综述总结了围产期抑郁症发病机制(神经递质失调、炎症、激素失衡和微生物群改变)的最新进展以及新兴的药物开发策略,同时还介绍了草药和膳食补充剂的临床证据。随机对照试验(RCT)的结果表明,虽然藏红花和维生素D等干预措施显示出一定前景,但仍存在重大局限性,包括疗效不一致、长期安全性数据有限以及与围产期生理的潜在相互作用。在全面研究证实天然干预措施的安全性和可靠性之前,仍需谨慎。本综述强调需要进行严格试验,以确定安全、有效的围产期抑郁症治疗方法,特别是针对弱势群体。